Octreotide versus terlypressin in acute variceal hemorrhage in liver cirrhosis Emergency control and prevention of early rebleeding

Sclerotherapy plus octreotide versus scl

Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial

✍ Massimo Pkimignani; Bruno Andreoni; Luca Carpinelli; Alfonso Capria; Gabriele Ro 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 659 KB

Because of its ability to decrease portal pressure, azygos blood flow, and postprandial splanchnic hyperemia, octreotide administration could be effective in reducing early rebleeding in patients undergoing endoscopic variceal sclerotherapy (EVS). We report the results of a trial comparing EVS + oct